CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00005276
NCT00005276N/ACompleted
CompareCT.gov

A Case Controlled Etiologic Study of Sarcoidosis (ACCESS)

National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted May 26, 2000·Updated Mar 25, 2016

In Brief

An observational study for Lung Diseases and Sarcoidosis. Completed.

Detailed Summary

To test specific hypotheses concerning environmental, occupational, lifestyle, and other risk factors for sarcoidosis. Also, to examine the familial aggregation of sarcoidosis and to test genetic hypotheses concerning its etiology. Finally, to describe the natural history of sarcoidosis, particularly in African-Americans who appear to be disproportionately affected, and to implement a system for storing biological specimens including blood cells, plasma, and serum.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLung Diseases, Sarcoidosis
Countries--
Collaborators--

Timeline

N/ACompletedFinished
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 26, 2000
Enrollment StartJun 1, 1995
Study CompletionMar 1, 2003
TodayJul 2, 2026
Posted 26.1 years ago